These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15752880)

  • 1. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy.
    Heemsbergen WD; Hoogeman MS; Hart GA; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1011-8. PubMed ID: 15752880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
    Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Hart AA; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):11-9. PubMed ID: 16757129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study.
    Fiorino C; Fellin G; Rancati T; Vavassori V; Bianchi C; Borca VC; Girelli G; Mapelli M; Menegotti L; Nava S; Valdagni R
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1130-7. PubMed ID: 17881142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
    Peeters ST; Lebesque JV; Heemsbergen WD; van Putten WL; Slot A; Dielwart MF; Koper PC
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1151-61. PubMed ID: 16414208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage.
    Heemsbergen WD; Peeters ST; Koper PC; Hoogeman MS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):3-10. PubMed ID: 16814954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy.
    Fokdal L; Honoré H; Høyer M; von der Maase H
    Radiother Oncol; 2005 Feb; 74(2):203-10. PubMed ID: 15734208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum.
    al-Abany M; Helgason AR; Cronqvist AK; Lind B; Mavroidis P; Wersäll P; Lind H; Qvanta E; Steineck G
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1035-44. PubMed ID: 15752882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of including clinical factors in rectal normal tissue complication probability modeling after radiotherapy for prostate cancer.
    Defraene G; Van den Bergh L; Al-Mamgani A; Haustermans K; Heemsbergen W; Van den Heuvel F; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1233-42. PubMed ID: 21664059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial.
    Nguyen PL; Chen RC; Hoffman KE; Trofimov A; Efstathiou JA; Coen JJ; Shipley WU; Zietman AL; Talcott JA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1081-5. PubMed ID: 20207497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
    Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in radiation dosimetry and anorectal function testing imply that anorectal symptoms may arise from different anatomic substrates.
    Smeenk RJ; Hopman WP; Hoffmann AL; van Lin EN; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):145-52. PubMed ID: 20950951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity.
    Söhn M; Alber M; Yan D
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):230-9. PubMed ID: 17707277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
    Karlsdóttir A; Muren LP; Wentzel-Larsen T; Dahl O
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1478-86. PubMed ID: 18060703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.
    Tucker SL; Cheung R; Dong L; Liu HH; Thames HD; Huang EH; Kuban D; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):353-65. PubMed ID: 15145148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased rectal wall stiffness after prostate radiotherapy: relation with fecal urgency.
    Krol R; Hopman WP; Smeenk RJ; Van Lin EN
    Neurogastroenterol Motil; 2012 Apr; 24(4):339-e166. PubMed ID: 22235913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.
    Valdagni R; Rancati T; Fiorino C; Fellin G; Magli A; Baccolini M; Bianchi C; Cagna E; Greco C; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Vavassori V
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1065-73. PubMed ID: 18234449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer.
    Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
    Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.